The market performance of Iovance Biotherapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $18.33 on 02/28/24, while the lowest value for the same duration was $3.21 on 10/19/23.
52-week price history of IOVA Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Iovance Biotherapeutics Inc’s current trading price is -45.88% away from its 52-week high, while its distance from the 52-week low is 209.03%. The stock’s price range during this period has spanned from $3.21 to $18.33. In the Healthcare sector, the Iovance Biotherapeutics Inc’s shares surpassed a trading volume of approximately 23.58 million for the day, which was noticeably higher compared to the average daily volume of 9.7.17 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly decline of -26.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.01B and boasts a workforce of 557 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.33, with a change in price of -4.11. Similarly, Iovance Biotherapeutics Inc recorded 6,370,803 in trading volume during the last 100 days, posting a change of -29.29%.
Examining IOVA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.09.
IOVA Stock Stochastic Average
Today, Iovance Biotherapeutics Inc’s raw stochastic average for the past 50 days stands at 92.13%, indicating a rise from the raw stochastic average of the last 20 days, which was 92.13%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 42.34% and 24.60% respectively.
IOVA Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 22.02% this year. Over the last six months, there has been a weaker performance of 14.29%. The price of IOVA fallen by 17.54% during the last 30 days period. For the last 5-days stocks have improved 27.34%.
